Oxford Global’s Q&A session with Formulation and Drug Delivery Congress speaker Bernardo Perez-Ramírez from Sanofi

Oxford Global’s Formulation and Drug Delivery Congress taking place on the 18^th & 19^th May being held at the Kensington Close Hotel in Kensington London, UK. The congress has over 150 senior level delegates attending over the two days. Delegates who represent leading biotech companies, global pharmaceutical organisations and internationally renowned academic institutions will be present. The congress has over 35 presentations and case studies focused on the key issues in formulation, drug delivery and product development, focusing on 4 interactive streams:

• Optimising Formulation
• Improving Drug Delivery
• Formulation and Drug Delivery Strategies
• Product Development Considerations

 

To download the full agenda please visit: http://www.formulation-congress.com/download-agenda-marketing/

 

In the lead up to the congress Bernardo Perez-Ramírez spoke with Oxford Global Conferences to discuss the latest movements within the industry. Bernardo Perez-Ramírez is the Senior Scientific Director of BioFormulations Development at Genzyme Corporation. He is responsible for development of formulations for therapeutic proteins to support phase I/II clinical studies, as well as pre-formulation research, drug delivery strategies and platform technology evaluation.

 

We asked Bernardo … What particular changes do you think researchers are facing in the field at the moment?

 

“!The main challenges in the area of formulation and drug delivery continues to be the need for rapid time to market while keeping innovation high, especially in the area of convenience devices for self-administration. Having the right balance is difficult, especially when markets are global with different regulatory requirements and manufacturers and suppliers are located off-shore.”

 

Bernardo shared with us his thoughts on the latest drug delivery technologies when we asked… Are there any particular drug delivery technologies that you think we should be paying close attention to at the moment?

 

“I believe that technologies that could offer a manufacturing friendly platform for drug delivery, good compatibility with the active component, as a miniature device, could continue be evolving and become very important in adding convenience to patients.”

 

Want to read more?

 

If you’d like to read the full Q&A please visit: http://www.formulation-congress.com/who-is-speaking/qa/

 

Oxford Global are delighted to announce the following speakers have been confirmed for our upcoming Formulation and Drug Delivery Congress.

 

Paul Stott

Vice President, Product Development UK, US & China, Pharmaceutical Development, AstraZeneca

 

Anand Subramony

VP Drug Delivery & Device Development, MedImmune

 

Holger Memmesheimer

VP Respiratory Drug Delivery, Boehringer Ingelheim

 

Joel Richard

Senior Vice President, Peptides – Head of CMCS Dreux Site, Ipsen

 

Thorsten Thormann

Senior Vice President, LEO Pharma

 

Bernardo Perez-Ramírez

Senior Scientific Director, Sanofi, Global Biotherapeutics

 

To view the full list of 2015 speakers please visit www.formulation-congress.com/who-is-speaking

 

Book your place today!

For further details please contact Danielle Dalby on +44 (0)1865 248455 or email d.dalby@oxfordglobal.co.uk

 

If you’re on Twitter, make sure to follow us on @FDDCongress and join the Congress conversation on #FDDC15